Europe Transcatheter Aortic Valve Replacement Market Size, 2028

Europe Transcatheter Aortic Valve Replacement Market Size, Share & Industry Trends Analysis Report By Material, By Implantation Procedure, By Mechanism (Balloon-expanding Valve and Self-expanding Valve), By End-use, By Country and Growth Forecast, 2022 - 2028

Published Date: February-2023 | Number of Pages: 101 | Format: PDF | Report ID: KBV-14315

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the Europe Transcatheter Aortic Valve Replacement Market

Market Report Description

The Europe Transcatheter Aortic Valve Replacement Market would witness market growth of 6.8% CAGR during the forecast period (2022-2028).

Several research groups are participating in a clinical research program that keeps running and enables patients’ access to cutting-edge technologies. Some examples of more recent experimental technology are TAVR valves with a smaller diameter, valves with improved sealing, and valves that may be adjusted for more precise placement.

The market opportunities being established by market participants due to the quick pace of clinical research in TAVR Innovations will benefit many heart patients who will profit from TAVR as a procedure for heart valve dysfunction. AVR is performed through extremely small gaps without jarring the chest bones.

As a result, the heart's aortic valve becomes thicker and calcified, preventing it from opening fully and reducing blood flow from the heart to the body's other organs. Heart failure and sudden heart fatalities may result from this. Patients experiencing symptoms and evidence of aortic stenosis are advised to undergo the implant. Patient's quality of life is enhanced with TAVR even if they would otherwise have few remaining therapy alternatives.

Over 1.8 million people in the European Union (EU) and 3.9 million people in Europe lose their lives to cardiovascular disease every year. Furthermore, 37% of all EU fatalities are attributable to CVD. The mortality rates from ischemic heart disease (IHD) and stroke are greater in Central and Eastern Europe compared to Northern, Southern, and Western Europe. Estimates place the number of people with CVD in Europe at 85 million, with about 49 million in the EU. This provides the participants in the transcatheter aortic valve replacement market in the Europe region with excellent growth potential.

The Germany market dominated the Europe Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $519.1 million by 2028. The UK market is anticipated to grow at a CAGR of 5.9% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.6% during (2022 - 2028).

Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Transcatheter Aortic Valve Replacement Market will Hit $8 Billion by 2028, at a CAGR of 7.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.

Scope of the Study

Market Segments Covered in the Report:

By Material

  • Nitinol
  • Stainless Steel
  • Cobalt-Chromium
  • Others

By Implantation Procedure

  • Transfemoral
  • Transapical
  • Transaortic

By Mechanism

  • Balloon-expanding Valve
  • Self-expanding Valve

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Medtronic PLC
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • TTK Healthcare Limited
  • Meril Life Science Private Limited
  • JenaValve Technology, Inc.
  • Bracco S.p.A

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Transcatheter Aortic Valve Replacement Market Report 2022-2028

North America Transcatheter Aortic Valve Replacement Market Report 2022-2028

Asia Pacific Transcatheter Aortic Valve Replacement Market Report 2022-2028

LAMEA Transcatheter Aortic Valve Replacement Market Report 2022-2028

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities